- Design
- Multicentre, open-label randomised trial
- Population
- 146 immunocompetent adults with suspected VAP or ventilated hospital-acquired pneumonia, France
- Primary outcome
- Targeted antibiotic therapy at 24 hours
- Effect
- 35.1% vs 23.6%, difference 11.5 points (95% CI −0.03 to 26.2); confirmed pneumonia 55.3% vs 31.0%
This French trial randomised 156 immunocompetent adults with suspected ventilator-associated or hospital-acquired pneumonia needing ventilation. Management used a multiplex PCR pneumonia panel plus conventional microbiology, or conventional microbiology alone. The primary outcome was the proportion on targeted antibiotic therapy at 24 hours; 146 patients were analysed.
Targeted therapy at 24 hours was 35.1% with PCR and 23.6% without, not a significant difference. In the 46% with culture-confirmed pneumonia, the figures were 55.3% and 31.0%. Other outcomes did not differ.
Rapid panels can speed targeted treatment, but only when there is a pathogen to find and clinicians act on the result. In Indian ICUs, where cost matters and carbapenem resistance is common, the value lies in using the panel for patients with a strong clinical and radiological case for pneumonia. It is not a screening test for every febrile ventilated patient.
- Reserve multiplex PCR panels for patients with a strong clinical case for pneumonia
- Act on results promptly, including de-escalation, or the test adds little
- Send conventional cultures as well, for susceptibility testing
- Interpret resistance-gene results alongside local resistance patterns
Why it matters
Rapid pathogen panels help only as much as the patients selected and the decisions made on the results.
Don't overread it
The benefit in culture-confirmed pneumonia is a subgroup finding, and the trial was small.
The statistics, in plain English
The overall difference of 11.5 percentage points has a confidence interval from about 0 to 26, so the trial cannot exclude no effect. The 24-point benefit in confirmed pneumonia is a subgroup defined after the fact by culture results, which makes it less reliable.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free